Amylin Pharmaceuticals, LLC

Overview

Amylin Pharmaceuticals, LLC is a biotechnology firm that specializes in the development of therapies for diabetes and other metabolic disorders. As a subsidiary of AstraZeneca, it leverages innovative research to create impactful healthcare solutions.

Therapeutic areas

API / Drug Master Files

Amylin Pharmaceuticals, LLC holds 2 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LISDEXAETAMINE DIMESYLATE INTActive2021-05-28
• LEVODOPAActive2020-06-29
• EXENDIN-4 INJECTION DRUG PRODUCTInactive1998-08-27

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Amylin Pharmaceuticals, LLC in our records. PharmaTek screens the full directory against live FDA enforcement data.